Defining an optimal therapeutic range for busulfan (Bu) administered with pre-and post-transplant cyclophosphamide (Cy) in HLA-matched related and unrelated bone marrow transplantation (BMT) (CROSBI ID 594588)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Lombardi, L ; Zahurak, M ; Durakovic, Nadira ; Kowalski, J ; Jones, RJ ; Luznik, L
engleski
Defining an optimal therapeutic range for busulfan (Bu) administered with pre-and post-transplant cyclophosphamide (Cy) in HLA-matched related and unrelated bone marrow transplantation (BMT)
The work tried to define an optimal therapeutic range for busulfan (Bu) administered with pre-and post-transplant cyclophosphamide (Cy) in HLA-matched related and unrelated bone marrow transplantation (BMT)
post-transplant cyclophosphamide; busulphan; BMT
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
3474-x.
2010.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Blood
0006-4971
Podaci o skupu
American Society of Hematology Annual Meeting
poster
03.12.2010-07.12.2010
Orlando (FL), Sjedinjene Američke Države
